---
title: "Allarity Therapeutics, Inc. (ALLR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ALLR.US.md"
symbol: "ALLR.US"
name: "Allarity Therapeutics, Inc."
industry: "Biotechnology"
---

# Allarity Therapeutics, Inc. (ALLR.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.allarity.com](https://www.allarity.com) |

## Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.89 | 182/605 | - | - | - |
| PB | 1.13 | 101/605 | 1.64 | 1.28 | 0.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-09T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.85 |
| Highest Target | 9.50 |
| Lowest Target | 9.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/ALLR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ALLR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ALLR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.